Illumina has bitten back against the attempt by billionaire activist investor Carl Icahn to introduce three members to its board, saying that they lack “experience in and
Three weeks after Redx Pharma and Jounce Therapeutics announced a merger, their plans have been disrupted by an unsolicited offer for Jounce from little-known Concentra Bi
Sanofi has agreed a deal to buy US biopharma company Provention Bio for $2.9 billion, taking control of a recently-approved type 1 diabetes (T1D) prevention therapy Tzield
Billionaire activist investor and ‘corporate raider’ Carl Icahn is lining up a proxy battle at Illumina in the wake of its troubled $7.1 billion takeover of blood-based ca
The latest crop of financings in the digital health category includes a sizeable $84 million round for Wellvana Health, with Genialis, ThoughtFull, and Mindset Health also
